# Lars Iversen

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/lars-iversen/

## Facts

| Field | Value |
| --- | --- |
| Citations | 18,161 |
| Field | Psoriasis: Treatment and Pathogenesis |
| h-index | 65 |
| i10-index | 257 |
| Last Known Institution | Aarhus University Hospital |
| OpenAlex ID | https://openalex.org/A5035700990 |
| ORCID iD | https://orcid.org/0000-0003-1816-4508 |
| Works | 451 |

## Researcher papers

- [Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial](https://scholariq.org/papers/mogamulizumab-versus-vorinostat-in-previously-treated-cutaneous-t-cell-lymphoma/)

## Researcher topics

- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Cutaneous lymphoproliferative disorders research](https://scholariq.org/topics/cutaneous-lymphoproliferative-disorders-research/)
- [NF-κB Signaling Pathways](https://scholariq.org/topics/nf-b-signaling-pathways/)

## Researcher university

- [Aarhus University Hospital](https://scholariq.org/institutions/aarhus-university-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.